Literature DB >> 10640146

hRAD54 gene and 1p high-resolution deletion-mapping analyses in oligodendrogliomas.

M J Bello1, J M de Campos, J Vaquero, P Ruiz-Barnés, M E Kusak, J L Sarasa, J A Rey.   

Abstract

The hRAD54 protein belongs to a superfamily of DNA helicases, and mutations in genes with DNA helicase function have been found to be responsible for cancer-prone syndromes (xeroderma pigmentosum, Bloom syndrome, Werner syndrome). hRAD54 thus could be a candidate modifier gene in tumors characterized by allelic imbalance at 1p32, the chromosome region in which this gene is located. Using a panel of 38 1p and five 1q markers, we therefore performed deletion-mapping analysis on a series of 35 oligodendrogliomas, which were also studied for mutations in the hRAD54 gene. Deletions of the short arm of chromosome 1 were evidenced in 26 tumors, mostly involving 1p36-1p13; all thus displayed loss of the 1p32 region. We used PCR/SSCP to examine all 18 exons of the hRAD54 gene for mutations in 25 tumors, but the mobility shifts detected corresponded to previously identified polymorphic changes: T-to-C transition at nucleotide 2865 (with no amino acid change) and at nucleotide 3008, at the 3' untranslated region. We conclude that hRAD54 gene alterations are not required for malignant transformation of oligodendrogliomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10640146     DOI: 10.1016/s0165-4608(99)00122-3

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

Review 1.  Molecular pathogenesis of oligodendroglial tumors.

Authors:  Judith W M Jeuken; Andreas von Deimling; Pieter Wesseling
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

Review 2.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

3.  Molecular diagnosis of metastasizing oligodendroglioma: a case report.

Authors:  Min Wang; Kathleen M Murphy; Piotr Kulesza; Kimmo J Hatanpaa; Alessandro Olivi; Anthony Tufaro; Yener Erozan; William H Westra; Peter C Burger; Karin D Berg
Journal:  J Mol Diagn       Date:  2004-02       Impact factor: 5.568

4.  Mutation analysis of the p73 gene in nonastrocytic brain tumours.

Authors:  M E Alonso; M J Bello; P Gonzalez-Gomez; J Lomas; D Arjona; J M de Campos; M E Kusak; J L Sarasa; A Isla; J A Rey
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

5.  Homozygous deletion of TNFRSF4, TP73, PPAP2B and DPYD at 1p and PDCD5 at 19q identified by multiplex ligation-dependent probe amplification (MLPA) analysis in pediatric anaplastic glioma with questionable oligodendroglial component.

Authors:  Miguel Torres-Martín; Carolina Peña-Granero; Fernando Carceller; Manuel Gutiérrez; Rommel R Burbano; Giovanny R Pinto; Javier S Castresana; Bárbara Melendez; Juan A Rey
Journal:  Mol Cytogenet       Date:  2014-01-06       Impact factor: 2.009

6.  Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumors.

Authors:  Jean-Louis Boulay; André R Miserez; Christian Zweifel; Balasubramanian Sivasankaran; Veronika Kana; Anthony Ghaffari; Cordelia Luyken; Michael Sabel; Abdessamad Zerrouqi; Morten Wasner; Erwin Van Meir; Markus Tolnay; Guido Reifenberger; Adrian Merlo
Journal:  PLoS One       Date:  2007-06-27       Impact factor: 3.240

7.  Identification of two contiguous minimally deleted regions on chromosome 1p36.31-p36.32 in oligodendroglial tumours.

Authors:  Z Dong; Jc-S Pang; M H Ng; W S Poon; L Zhou; H-K Ng
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.